Cancer Incidence and Mortality among Non-Hispanic Black Individuals, New York State Excl New York City, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 4,962.0 481.7 475.6-487.9 2,565.8 567.5 557.2-577.9 2,396.2 423.8 416.1-431.6 1,525.6 155.3 151.7-158.9 753.6 186.8 180.6-193.2 772.0 135.9 131.6-140.3
Oral cavity and pharynx 86.8 8.2 7.4-9.0 57.6 12.1 10.7-13.6 29.2 5.1 4.3-6.1 20.8 2.0 1.6-2.4 15.8 3.5 2.8-4.4 5.0 0.8 0.5-1.3
Esophagus 38.0 3.9 3.3-4.5 24.2 6.1 5.0-7.4 13.8 2.4 1.8-3.0 29.4 3.0 2.5-3.5 20.8 5.3 4.3-6.5 8.6 1.5 1.0-2.0
Stomach 110.8 11.3 10.4-12.3 57.0 13.5 11.9-15.3 53.8 9.7 8.6-11.0 43.6 4.5 3.9-5.1 24.6 6.0 4.9-7.2 19.0 3.4 2.7-4.1
Colorectal 411.8 40.8 39.0-42.6 212.0 48.8 45.8-52.0 199.8 35.2 33.1-37.5 143.6 14.5 13.4-15.6 75.8 18.3 16.4-20.4 67.8 11.9 10.7-13.3
Colon excluding rectum 298.0 29.8 28.3-31.4 145.8 34.3 31.7-37.0 152.2 26.9 25.0-28.9 119.0 12.1 11.1-13.1 62.2 15.2 13.5-17.1 56.8 10.0 8.8-11.2
Rectum & rectosigmoid 113.8 11.0 10.1-11.9 66.2 14.5 12.9-16.2 47.6 8.4 7.3-9.5 24.6 2.5 2.0-2.9 13.6 3.1 2.4-4.0 11.0 2.0 1.5-2.6
Liver / intrahepatic bile duct 119.6 10.8 9.9-11.7 86.0 17.5 15.8-19.3 33.6 5.5 4.7-6.5 79.6 7.6 6.9-8.4 54.4 11.8 10.4-13.3 25.2 4.4 3.6-5.2
Pancreas 170.4 17.2 16.0-18.4 80.2 18.8 16.9-20.8 90.2 15.9 14.4-17.4 128.0 13.1 12.1-14.2 61.4 14.8 13.1-16.6 66.6 11.8 10.6-13.2
Larynx 33.8 3.2 2.7-3.7 26.4 5.7 4.8-6.8 7.4 1.2 0.9-1.7 10.6 1.0 0.8-1.3 8.6 2.0 1.4-2.7 2.0 0.3 0.2-0.6
Lung and bronchus 569.8 56.1 54.0-58.2 294.8 69.4 65.7-73.2 275.0 47.2 44.7-49.8 315.2 31.6 30.0-33.2 175.8 43.3 40.3-46.4 139.4 23.9 22.1-25.7
Melanoma of the skin 10.4 1.1 0.8-1.4 4.2 1.0 0.6-1.6 6.2 1.1 0.7-1.6 2.0 0.2 0.1-0.4 1.0 0.2 0.1-0.6 1.0 0.2 0.1-0.4
Female breast             747.0 133.6 129.3-138.1             137.4 24.4 22.6-26.4
Cervix uteri             43.0 7.8 6.8-9.0             14.0 2.5 1.9-3.2
Corpus uterus and NOS             187.4 31.8 29.7-33.9             52.2 9.0 7.9-10.2
Ovary             46.6 8.2 7.2-9.4             28.0 5.0 4.2-5.9
Prostate       1,021.6 215.8 209.6-222.1             103.2 29.1 26.6-31.8      
Testis       9.4 1.8 1.3-2.4             0.0 0.0 0.0-0.2      
Urinary bladder (incl. in situ) 127.8 13.0 12.0-14.0 86.4 21.1 19.1-23.3 41.4 7.3 6.4-8.4 25.2 2.8 2.3-3.3 15.4 4.4 3.5-5.6 9.8 1.7 1.3-2.3
Kidney and renal pelvis 201.4 19.4 18.2-20.6 128.4 27.4 25.2-29.7 73.0 13.0 11.7-14.4 23.8 2.4 2.0-2.9 14.8 3.4 2.7-4.3 9.0 1.7 1.2-2.2
Brain and other central nervous system 42.4 4.1 3.6-4.7 22.0 4.7 3.8-5.7 20.4 3.7 3.0-4.5 25.8 2.5 2.1-3.0 12.6 2.6 2.0-3.3 13.2 2.4 1.8-3.0
Thyroid 104.6 10.2 9.4-11.2 21.6 4.7 3.8-5.7 83.0 15.4 14.0-17.0 6.0 0.7 0.4-0.9 2.6 0.7 0.3-1.2 3.4 0.6 0.4-1.0
Hodgkin lymphoma 29.6 2.8 2.4-3.3 14.6 3.0 2.3-3.8 15.0 2.7 2.1-3.4 2.2 0.2 0.1-0.4 1.8 0.4 0.2-0.8 0.4 0.1 0.0-0.2
Non-Hodgkin lymphomas 161.8 16.0 14.9-17.2 88.8 19.8 17.9-21.8 73.0 13.1 11.7-14.5 40.2 4.1 3.5-4.7 23.6 5.7 4.6-6.8 16.6 3.0 2.4-3.7
Myeloma 151.4 15.1 14.0-16.2 77.4 18.2 16.3-20.2 74.0 12.9 11.6-14.3 48.6 5.2 4.6-5.9 25.0 6.8 5.6-8.1 23.6 4.3 3.5-5.1
Leukemias 113.6 11.3 10.3-12.2 59.6 13.6 12.0-15.3 54.0 9.7 8.5-10.9 51.0 5.3 4.6-6.0 26.4 6.6 5.4-7.9 24.6 4.4 3.7-5.3

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.